SOPHiA GENETICS SA (SOPH) Tops Q3 EPS by 8c

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q3 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $15.63 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.

You May Also Be Interested In

• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Morgan Stanley Resumes Bath & Body Works Inc. (BBWI) at Equalweight
• Morgan Stanley Resumes Tapestry Inc. (TPR) at Overweight